Post by Global News on
‘Blood on Its Hands’: (US) FDA Will Remove Anti-ivermectin Social Media, Website Posts Under Lawsuit Settlement Agreement Below excerpt reported by Baletti. B., Ph.D. (2024, March 22). ‘Blood on Its Hands’: FDA Will Remove Anti-ivermectin Social Media, Website Posts Under Lawsuit Settlement Agreement. The Defender — Children’s Health Defense’s News & Views “The FDA demonized ivermectin, which is a highly effective drug for the early treatment of COVID. The consequences of this, and what has to be clear is that this led directly to the death of millions of people,” Marik said. “So the FDA has blood on its hands.” Marik said if the drug had been widely used early in the course of the pandemic, it would have significantly reduced the risk of death. Instead, the FDA interfered with the practice of medicine, demonizing the drug, which led to doctors being prohibited from using it and pharmacists being prohibited from dispensing it. In the U.S., it’s common and legal for doctors to prescribe drugs off-label, or for a different purpose than it is approved for. Marik said 40-60% of medications are used off-label. “It’s standard of care,” he said, which is the benchmark that determines whether professional obligations to fully and effectively care for patients have been met. “The FDA was actually caught out in a big lie,” he said, because the agency allows and promotes the use of off-label drugs “as long as it doesn’t interfere with their EUA [emergency use authorization].”Ivermectin is an effective antiparasitic drug that’s been given to billions of people worldwide. It was discovered in the 1970s by Japanese microbiologist Satoshi Ōmura, Ph.D., and American parasitic biologist William C. Campbell, Ph.D., who won the 2015 Nobel Prize in Physiology for their discovery. The FDA approved the drug in 1996 to treat several tropical diseases, including onchocerciasis, helminthiasis and scabies. After many doctors across the country began prescribing ivermectin for COVID-19 early in the pandemic, the FDA launched a campaign against the drug, despite numerous studies — including studies posted on its own website — showing ivermectin could be effective as an early intervention against COVID-19, and the drug’s strong safety profile. The drug was also administered widely in several countries, including India, Mexico and Argentina. To read full article, click here Also reported in Hindustan Times - 'Blood on its hands': FDA loses battle against ivermectin, agrees to remove COVID-related anti-drug social media posts. Reported by Kukreti. S. Image from The Defender — Children’s Health Defense’s News & Views Legal Disclaimer: INFYNIT is providing the content here for educational purposes only. All opinions are of the original author and not an opinion of INFYNIT or any of its affiliates. #GlobalNews #Ivermectin #US #FDA #Lawsuit